Regulation of Erythropoiesis by the VDR Nuclear Receptor Transcription Factor
VDR 核受体转录因子对红细胞生成的调节
基本信息
- 批准号:9052176
- 负责人:
- 金额:$ 38.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-06 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdultBFU-EBindingBinding SitesBiological AssayBone MarrowCFU-ECalcitriolCalcium BindingCell CycleCell LineCell LineageCell NucleusCell ProliferationCellsCholecalciferolClinicalComplexDNA BindingDevelopmentDexamethasoneEmbryoErythroblastsErythrocyte TransfusionErythrocytesErythroidErythroid Progenitor CellsErythropoiesisFetal LiverGene TargetingGenesGeneticGlucocorticoidsGoalsGrowthHealthHumanLeukemic CellLigandsLiquid substanceMethylcelluloseMolecularMusMyelogenousNuclear ReceptorsPathway interactionsPhenotypePhosphotransferasesPopulationProductionProteinsProto-Oncogene Protein c-kitPublishingRNAReceptor ActivationReceptor SignalingRecruitment ActivityRegulationReverse Transcriptase Polymerase Chain ReactionRoleSignal PathwaySignal TransductionSpleenStem cellsStressSubfamily lentivirinaeTimeTranscriptTranscriptional RegulationVitamin DVitamin D3 Receptorbasebonec-myc Geneserythroid differentiationfactor Aknock-downloss of functionnext generationnovelnovel strategiesnovel therapeuticsprogenitorrab GTP-Binding Proteinsreceptor bindingresponseself-renewalsmall hairpin RNAstemtranscription factortranscriptome sequencing
项目摘要
DESCRIPTION (provided by applicant): Red blood cell progenitors undergo self-renewing divisions prior to the commitment switch to erythroid differentiation but the pathways that regulate erythroid progenitor growth are still largely unknown. In a computational search for genes expressed in definitive (adult) but not primitive (embryonic) red cell lineages, we identifie the nuclear receptor transcription factor VDR, which is activated by binding to its ligand, vitamin
D3 (1,25(OH)2D3). Real-time RT-PCR analysis indicated that Vdr is expressed in definitive erythroid progenitors from mouse fetal liver and bone marrow and is downregulated during erythroid maturation. Structural studies have shown that VDR activation by the vitamin D3 ligand results in significant conformational changes that stabilize the protein and induce its translocation into the nucleus, where it recruits coregulatory complexes. The VDR signaling pathway has been studied mostly in bone. The regulation of erythropoiesis by this pathway has been essentially unexplored; published studies were performed almost entirely in leukemic cell lines (not normal primary cells). We find that vitamin D3 stimulates the growth of erythroid progenitors (BFU-E and CFU-E) from mouse fetal liver and bone marrow. Not only the numbers but also the size of the BFU-E colonies is increased when the VDR pathway is activated. The CD71low subset of c-Kit+ fetal liver progenitors, which contains BFU-E, is the most sensitive to activation of VDR. Progenitors cultured with vitamin D3 differentiate normally. Vitamin D3 can partially substitute for dexamethasone (a glucocorticoid) in progenitor cultures, suggesting a possible role in stress erythropoiesis. We hypothesized that VDR activates or represses genes in developing erythroid progenitors in combination with erythroid transcription factors (TFs) such as Gata, Klf1/Eklf, and Scl/tal and that DNA binding sites for VDR may cluster with binding sites for erythroid TFs. A computational approach based on this hypothesis was used to identify candidate VDR target genes in erythroid progenitors. We have begun to confirm the vitamin D3 responsiveness of some of these genes using real-time RT-PCR. The candidates include genes known to function in erythropoiesis (c-Myc, Gata2) and others that were not (Calcium binding kinase Camk1d; N-Myc; Mlx-interacting protein, a bHLH transcription factor; Grtp1, GTPase Rab activator). We hypothesize that the VDR pathway controls erythroid progenitor cell proliferation and/or survival, at least in part through transcriptional regulation of target genes.
The goal of this project is to elucidate the molecular mechanisms by which vitamin D regulates red blood cell development.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret H Baron其他文献
Margaret H Baron的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margaret H Baron', 18)}}的其他基金
Regulation of Erythroid Cell Progenitors by the Nuclear Receptor Transcription Factor VDR
核受体转录因子 VDR 对红细胞祖细胞的调节
- 批准号:
10392918 - 财政年份:2015
- 资助金额:
$ 38.14万 - 项目类别:
Regulation of Erythropoiesis by the VDR Nuclear Receptor Transcription Factor
VDR 核受体转录因子对红细胞生成的调节
- 批准号:
9260873 - 财政年份:2015
- 资助金额:
$ 38.14万 - 项目类别:
Regulation of Erythroid Cell Progenitors by the Nuclear Receptor Transcription Factor VDR
核受体转录因子 VDR 对红细胞祖细胞的调节
- 批准号:
9976495 - 财政年份:2015
- 资助金额:
$ 38.14万 - 项目类别:
Research Training Program in Molecular and Cellular Hematology
分子和细胞血液学研究培训计划
- 批准号:
7939604 - 财政年份:2009
- 资助金额:
$ 38.14万 - 项目类别:
Research Training Program in Molecular and Cellular Hematology
分子和细胞血液学研究培训计划
- 批准号:
7762477 - 财政年份:2009
- 资助金额:
$ 38.14万 - 项目类别:
Research Training Program in Molecular and Cellular Hematology
分子和细胞血液学研究培训计划
- 批准号:
8128585 - 财政年份:2009
- 资助金额:
$ 38.14万 - 项目类别:
Research Training Program in Molecular and Cellular Hematology
分子和细胞血液学研究培训计划
- 批准号:
8496860 - 财政年份:2009
- 资助金额:
$ 38.14万 - 项目类别:
Research Training Program in Molecular and Cellular Hematology
分子和细胞血液学研究培训计划
- 批准号:
8320212 - 财政年份:2009
- 资助金额:
$ 38.14万 - 项目类别:
相似国自然基金
生脉注射液对再障大鼠BFU-E、CFU-E中PRPP合成酶影响
- 批准号:39670908
- 批准年份:1996
- 资助金额:10.0 万元
- 项目类别:面上项目
相似海外基金
CIRCULATING BFU-E HETEROGENEITY IN SICKLE CELL ANEMIA
镰状细胞性贫血中循环 BFU-E 的异质性
- 批准号:
6241975 - 财政年份:1997
- 资助金额:
$ 38.14万 - 项目类别:
人T細胞SubpopulatinonのBFU-e分化におよぼす影響
人 T 细胞亚群对 BFU-e 分化的影响
- 批准号:
57771639 - 财政年份:1982
- 资助金额:
$ 38.14万 - 项目类别:
Grant-in-Aid for Encouragement of Young Scientists (A)
BFU-E COLONY GROWTH RESPONSE TO HYDROXYUREA--RELATION TO HEMOGLOBIN F INDUCTION
BFU-E 菌落生长对羟基脲的反应--与血红蛋白 F 诱导的关系
- 批准号:
6324734 - 财政年份:
- 资助金额:
$ 38.14万 - 项目类别:
CIRCULATING BFU-E HETEROGENEITY IN SICKLE CELL ANEMIA
镰状细胞性贫血中循环 BFU-E 的异质性
- 批准号:
5213669 - 财政年份:
- 资助金额:
$ 38.14万 - 项目类别:














{{item.name}}会员




